NCT02585687

✓ Unanimous Initial: hospital Requery: hospital — The liver Perfusion MRI is performed on patients to assess their response to treatment, indicating the intervention requires hospital-based equipment and services, typical of an inpatient setting. Thinking: other — The liver perfusion MRI is an outpatient imaging procedure, not requiring inpatient hospital admission.

✓ Unanimous Initial: other

✓ Unanimous Initial: hospital Requery: other — The study involves MRI scanning procedures for hepatocellular carcinoma patients, which are typically performed in outpatient radiology departments or imaging centers rather than requiring hospital admission. Thinking: other — The intervention is liver perfusion MRI performed at a medical center's radiology department as an outpatient procedure, not requiring hospital admission.

✓ Unanimous Initial: feasibility RCT Requery: feasibility RCT — The study has a small sample size of 28 and does not focus on clinical effectiveness but rather on early assessment of treatment response using imaging, indicating it is likely a pilot study. Thinking: N/A — Single-group interventional study, not a randomized controlled trial.

✓ Unanimous Initial: N/A Requery: N/A — The study uses a single-group, non-randomized design to assess a diagnostic device (Perfusion MRI), meaning it is not an RCT.

✓ Unanimous Initial: N/A Requery: feasibility RCT — With only 28 participants and primary outcomes focused on treatment response evaluation rather than definitive clinical effectiveness, this appears to be a feasibility study assessing the utility of perfusion MRI as an early predictor of treatment response. Thinking: N/A — Single-group interventional study without randomization or control group, not an RCT

✓ Unanimous Initial: no Requery: no — The intervention being tested is the use of liver Perfusion MRI to assess early response to treatments, not a screening tool for identifying palliative care needs. Thinking: no — The study evaluates MRI as a diagnostic tool for treatment response, not a screening instrument for palliative-care needs.

✓ Unanimous Initial: yes Requery: yes — The clinical trial's primary purpose is screening, and the intervention being tested is the use of Liver Perfusion MRI to screen for or assess the early response to antiangiogenic treatments in hepatocellular carcinoma.

✓ Unanimous Initial: yes Requery: no — The intervention is liver perfusion MRI being tested as an imaging technique to assess treatment response in hepatocellular carcinoma patients, not a screening tool to identify palliative care needs. Thinking: no — The liver perfusion MRI is being used to assess treatment response to antiangiogenic therapy, not as a screening tool to identify palliative care needs.